- Ollie Bearman is now the latest elite athlete to invest in Prenetics (NASDAQ:PRE), demonstrating strong confidence in the brand’s mission and offerings.
- IM8, co-founded by David Beckham, continues to attract leading athletes who prioritize scientifically proven and reliable nutritional support.
- IM8 has emerged as one of the fastest-growing supplement brands globally, achieving an impressive US$100 million in Annual Recurring Revenue within just 11 months of its launch.
- Bearman’s rapid ascent – including a memorable points-scoring Ferrari debut at only 18 – solidifies his standing as one of motorsport’s most promising young talents.
NEW YORK, Feb. 13, 2026 — Prenetics Global Limited (NASDAQ: PRE), a prominent consumer health sciences company and the parent organization of the IM8 premium health and longevity brand, today announced that Formula 1 sensation Ollie Bearman has joined as its newest Global Ambassador and a shareholder. This collaboration marks another significant achievement for IM8 as it continues to attract and partner with world-class athletes who exemplify peak performance and a dedication to health excellence.
At merely 18 years old, Bearman made a remarkable entry into Formula 1 when he was unexpectedly called upon to race for Ferrari at the 2024 Saudi Arabian Grand Prix, securing an impressive 7th place finish and becoming the youngest British driver ever to start a World Championship Grand Prix. This breakthrough performance established him as one of the youngest drivers in modern F1 history to score points in his debut race. Before his F1 opportunity, he achieved outstanding results in junior categories, including 17 race victories in a single Formula 4 season and multiple Formula 2 wins at iconic tracks like Baku and Barcelona. These accomplishments paved the way for his first full Formula 1 season in 2025, where he gained valuable experience and further demonstrated maturity and composure beyond his years. He now embarks on his second full season in Formula 1 as the 2026 campaign commences, continuing his trajectory as one of the sport’s most thrilling young talents and a genuine generational prospect.
The partnership with IM8 began after Ollie experienced notable performance enhancements from incorporating IM8’s flagship product, Daily Ultimate Essentials, into his demanding training and competition regimen. The product’s NSF Certified for Sport® designation provided the assurance of quality and safety essential for an athlete competing at the pinnacle of motorsport.
“In Formula 1, every millisecond is crucial, and the physical and mental demands are immense. Your body and mind must perform at their absolute peak,” stated Ollie Bearman. “I was introduced to IM8 and was immediately impressed by the scientific foundation and the caliber of experts they collaborate with. After using the product, I observed a significant improvement in my energy levels, focus on the track, and recovery between races. Trust is paramount in my profession, and IM8’s dedication to the NSF Certified for Sport® certification gives me complete confidence. I am not merely endorsing this brand; I am investing in it because I believe in the product and the team. It is an honor to join David Beckham and the IM8 family to promote the importance of foundational health to a global audience.”
Danny Yeung, CEO of Prenetics, commented, “We are delighted to welcome Ollie Bearman to the IM8 and Prenetics family. Ollie is an individual who has already delivered extraordinary performances at an age when most drivers are still years away from Formula 1. His composure under pressure, rapid progression through the ranks, and historic Ferrari debut make him precisely the kind of next-generation athlete IM8 champions.
At just 20 years old, he already understands that optimal performance begins with the right foundation, and that mindset perfectly aligns with what IM8 represents. The fact that this partnership developed organically, with Ollie initially being a genuine user of the product, speaks volumes about the effectiveness and trust that IM8 has cultivated. Having a young driver with his ambition and potential not only as an ambassador but also as a shareholder is incredibly exciting and reinforces our commitment to providing best-in-class, science-backed nutritional supplements to the next generation of athletes and health-conscious consumers worldwide.”
IM8 has shown unparalleled growth since its launch in December 2024, establishing itself as a significant force in the global supplement market. The brand’s success is built upon a foundation of scientific credibility, supported by a Scientific Advisory Board that includes experts from world-renowned institutions such as the Mayo Clinic, Cedars-Sinai, and others.
IM8’s Daily Ultimate Essentials is available at .
Press Kit:
About Prenetics
Prenetics (NASDAQ: PRE) is a leading health sciences company committed to advancing human health and longevity. The Company’s flagship consumer brand, IM8, co-founded with David Beckham and endorsed by World No. 1 tennis player Aryna Sabalenka, is redefining the premium daily nutrition category through scientifically validated formulations and global brand partnerships. Since its inception, IM8 has become one of the fastest-growing brands in consumer health, exceeding $100 million in annualized revenue within 11 months, and is now sold in over 30 countries worldwide.
About IM8
IM8 represents the pinnacle of premium core nutrition, originating from a collaboration between David Beckham as a co-founding partner, and an elite team of scientists encompassing medical professionals, academia, and space science. Combining cutting-edge science with nature’s most potent ingredients, IM8 offers a holistic, science-backed approach to health, empowering you to live your most vibrant life. IM8’s flagship product, Daily Ultimate Essentials, is an all-in-one powder supplement engineered to replace 16 different supplements in a delicious drink and is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors, or sweeteners. IM8 is a subsidiary of Prenetics (NASDAQ: PRE), a leading global health sciences company dedicated to advancing consumer health. To learn more about IM8, please visit www.IM8health.com.
Investor Relations Contact:
Angela Cheung
Investor Relations / Corporate Finance
Photos accompanying this announcement are available at
